Capitolis Liquid Global Markets »

Regeneron Pharmaceuticals shares owned by Capitolis Liquid Global Markets

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Capitolis Liquid Global Markets from 13F filings

Historical chart of Capitolis Liquid Global Markets investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Capitolis Liquid Global Markets consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Capitolis Liquid Global Markets

Quarter filed Position value Share count Share price at filing
2024-09-30 $40M 38k 1051.24
2024-06-30 $40M 38k 1051.03

More positions owned by Capitolis Liquid Global Markets

Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Eli Lilly & Co. (LLY)
Mastercard Incorporated Cl A (MA)
Amazon (AMZN)
Broadcom (AVGO)
Wal-Mart Stores (WMT)
ConocoPhillips (COP)
Booking Holdings (BKNG)
UnitedHealth (UNH)
Cisco Systems (CSCO)
Thermo Fisher Scientific (TMO)

View all positions for Capitolis Liquid Global Markets

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
State Street Corporation
Capital World Investors
Capital Research and Management Company - Division 3
Dodge & Cox
Geode Capital Management
Franklin Resources
T. Rowe Price Associates
Loomis, Sayles and
Invesco
Bank of America Corporation
Amundi

View all funds holding Regeneron Pharmaceuticals